argus

Alkem Laboratories Limited

NSE: ALKEMINE540L0101462,293 Cr

Timeline

Time (IST)TypeMEventSrc
13 Feb, 02:17 pmAlkem Laboratories Limited has informed the Exchange about Change in Conference Call Participantsnse
13 Feb, 02:12 pmAlkem Laboratories Limited has informed the Exchange about Investor Presentationnse
13 Feb, 02:09 pmAlkem Laboratories Limited has informed the Exchange about This is to inform you that M/s. Alkem Medtech Private Limited, a wholly owned subsidiary of the Company in India has offered to acquire at least 51% and upto 55% of the issued share capital of M/s. Occlutech Holding AG ( Occlutech ) from certain of the Occlutech s current shareholders for cash consideration.nse
13 Feb, 02:07 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
13 Feb, 02:06 pmAlkem Laboratories Limited has informed the Exchange about Attached please find update on incorporation of JV in Saudinse
13 Feb, 02:04 pmAlkem Laboratories Limited has informed the Exchange about Amendment(s)nse
13 Feb, 02:02 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Acquisitionbse
13 Feb, 02:01 pmAlkem Laboratories Limited has informed the Exchange about Amalgamation/Mergernse
13 Feb, 01:58 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
13 Feb, 01:58 pmAlkem Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on February 13, 2026, declared Interim Dividend of Rs. 43 per equity share.nse
13 Feb, 01:58 pmAlkem Laboratories Ltd - 539523 - Corporate Action-Board approves Dividendbse
13 Feb, 01:57 pmAlkem Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 20-Feb-2026.nse
13 Feb, 01:56 pmAlkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 (LODR) - Amendment Cum Supplemental Agreementbse
13 Feb, 01:55 pmAlkem Laboratories Ltd - 539523 - Results- Unaudited Financial Results For Quarter And Nine Months Ended 31St Dec, 2025bse
13 Feb, 01:54 pmAlkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
13 Feb, 01:51 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Scheme of Arrangementbse
13 Feb, 01:50 pmAlkem Laboratories Limited has informed the Exchange about Outcome of Board Meeting held on 13th February, 2026nse
13 Feb, 01:50 pmAlkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 13Th Feb, 2026bse
12 Feb, 11:07 amRevised intimation of Conference Call on Q3FY26 and 9MFY26 financial results Change in Conference Call Timingnse
06 Feb, 01:55 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Scheme of Arrangementbse
06 Feb, 01:51 pmAlkem Laboratories Limited has informed the Exchange about Amalgamation/Mergernse
23 Jan, 01:30 pmAlkem Laboratories Ltd - 539523 - Board Meeting Intimation for Board Meeting Intimation For Notice Of Meeting Of Board Of Directors Of Alkem Laboratories Limited.bse
22 Jan, 03:14 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI LODRbse
22 Jan, 03:12 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
17 Jan, 10:18 amAlkem Laboratories Ltd - 539523 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
13 Jan, 04:26 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI LODRbse
13 Jan, 04:22 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
08 Jan, 03:03 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
08 Jan, 03:02 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated January 08, 2026, titled "Alkem launches Renocia cyclical therapy, a nutritional supplements kit, to support hair growth".nse
01 Jan, 12:32 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI LODRbse
01 Jan, 12:27 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
30 Dec, 05:11 pmAlkem Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ( SEBI LODR Regulations )- Update on transfer of the trade generics business of the Companynse
30 Dec, 05:10 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
30 Dec, 04:10 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI LODR.bse
30 Dec, 04:08 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
30 Dec, 01:11 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI LODR.bse
30 Dec, 01:09 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
30 Dec, 12:23 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
29 Dec, 03:05 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI LODR.bse
29 Dec, 03:02 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
26 Dec, 07:01 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Acquisitionbse
26 Dec, 06:59 pmAlkem Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI LODR Regulations.nse
26 Dec, 06:24 pmAlkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
16 Dec, 11:13 amAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
16 Dec, 11:13 amAlkem Laboratories Limited has informed the Exchange regarding Appointment of Mr. Sunil Sawant as Senior Management Personnel of the company w.e.f. December 16, 2025.nse
12 Dec, 01:03 pmAlkem Laboratories Limited has informed the Exchange regarding Cessation of Mr. Vijay Shetty as Senior Management Position of the company w.e.f. December 12, 2025.nse
12 Dec, 12:50 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
10 Dec, 10:47 amAlkem Laboratories Limited has informed the Exchange about GMP Inspection by Malta Medicines Authority at Company's manufacturing facility located at Daman, India.nse
08 Dec, 11:32 amAlkem Laboratories Limited has informed the Exchange regarding Cessation of Mr Rakesh Tripathi as Senior Management Position of the Company w.e.f. December 08, 2025.nse
08 Dec, 11:27 amAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse